We stratified the analysis according to the AFP value and HCC CIF of recurrence at 10 years from LT was significant higher in patients with an AFP > 25.5 [34.3% (95% CI 21.0–48.0%) vs. 11.5% (6.3–18.4%) (p = 0.001)]. This evidence concerns the gene AFP and hepatocellular carcinoma.